VIBROCIL 2.5mg / 0.25mg / ml nose drops solution medication leaflet

R01AB01 phenylephrine + dimethindene • Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, combinations excl. corticosteroids

The combination of phenylephrine and dimetindene is used for the treatment of symptoms of allergic rhinitis and nasal congestion. Phenylephrine acts as a decongestant, while dimetindene is an antihistamine that reduces allergic reactions such as itching and sneezing.

The medication is available in the form of nasal sprays or solutions and should be used as directed by your doctor. It is important not to exceed the recommended dose and to avoid long-term use without medical supervision.

Side effects may include dryness of the nasal mucosa, dizziness, drowsiness, or, in rare cases, severe allergic reactions.

Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of this combination.

General data about VIBROCIL 2.5mg / 0.25mg / ml

Substance: phenylephrine + dimethindene

Date of last drug list: 01-03-2024

Commercial code: W69985001

Concentration: 2.5mg / 0.25mg / ml

Pharmaceutical form: nose drops solution

Packing volume: 15ml

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: NOVARTIS CONSUMER HEALTH GMBH - GERMANIA

Holder: HALEON ROMANIA S.R.L. - ROMANIA

Number: 12056/2019/01

Shelf life: 3 years

Pharmaceutical forms available for phenylephrine + dimethindene

Concentrations available for phenylephrine + dimethindene

2.5mg/0.25mg/g, 2.5mg/0.25mg/ml

Other substances similar to phenylephrine + dimethindene